Case 1:18-cv-12029-ADB Document 287 Filed 03/28/22 Page 1 of 5
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`Plaintiffs,
`
`v.
`
`ELI LILLY AND COMPANY,
`
`Defendant.
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`STIPULATION AND ORDER REGARDING ASSERTED CLAIMS
`
`Plaintiffs Teva Pharmaceuticals International GmbH; and Teva Pharmaceuticals USA, Inc.
`
`(collectively, “Plaintiffs” or “Teva”) and Defendant Eli Lilly and Company (“Lilly”) (collectively,
`
`the “Parties”) have agreed to enter into this stipulation to streamline the issues in dispute in this
`
`matter, subject to the approval of the Court;
`
`WHEREAS, Teva has asserted claims 1, 3–4, 8–9, 12, 15–16, 24, 27, and 30–31 of U.S.
`
`Patent No. 8,586,045 (the “’045 patent”); claims 1, 4–7, 15, and 17 of U.S. Patent No. 9,884,907
`
`(the “’907 patent”); and claims 1, 4–7, 15, and 17 of U.S. Patent No. 9,884,908 (the “’908 patent”)
`
`against Lilly; and
`
`WHEREAS the Parties seek to reduce the number of claims and defenses to streamline the
`
`issues for trial, and accordingly hereby agree to dismiss certain claims and certain corresponding
`
`counterclaims and defenses.
`
`NOW THEREFORE, IT IS HEREBY STIPULATED AND AGREED, by and between
`
`the Parties hereto, and subject to the approval of the Court, as follows:
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`Plaintiffs,
`
`v.
`
`ELI LILLY AND COMPANY,
`
`Defendant.
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`STIPULATION AND ORDER REGARDING ASSERTED CLAIMS
`
`Plaintiffs Teva Pharmaceuticals International GmbH; and Teva Pharmaceuticals USA, Inc.
`
`(collectively, “Plaintiffs” or “Teva”) and Defendant Eli Lilly and Company (“Lilly”) (collectively,
`
`the “Parties”) have agreed to enter into this stipulation to streamline the issues in dispute in this
`
`matter, subject to the approval of the Court;
`
`WHEREAS, Teva has asserted claims 1, 3–4, 8–9, 12, 15–16, 24, 27, and 30–31 of U.S.
`
`Patent No. 8,586,045 (the “’045 patent”); claims 1, 4–7, 15, and 17 of U.S. Patent No. 9,884,907
`
`(the “’907 patent”); and claims 1, 4–7, 15, and 17 of U.S. Patent No. 9,884,908 (the “’908 patent”)
`
`against Lilly; and
`
`WHEREAS the Parties seek to reduce the number of claims and defenses to streamline the
`
`issues for trial, and accordingly hereby agree to dismiss certain claims and certain corresponding
`
`counterclaims and defenses.
`
`NOW THEREFORE, IT IS HEREBY STIPULATED AND AGREED, by and between
`
`the Parties hereto, and subject to the approval of the Court, as follows:
`
`
`
`Case 1:18-cv-12029-ADB Document 287 Filed 03/28/22 Page 2 of 5
`
`1.
`
`Teva stipulates that it voluntarily dismisses its claims of infringement against Lilly
`
`of claims 1, 3–4, 8–9, 12, 15–16 and 31 of the ’045 patent, claim 7 of the ’907 patent, and claim 7
`
`of the ’908 patent pertaining to Lilly’s Emgality® (galcanezumab-gnlm) product with prejudice
`
`pursuant to Fed. R. Civ. P. 41(a)(2).
`
`2.
`
`Lilly stipulates that it voluntarily dismisses its defenses and counterclaims of
`
`invalidity and non-infringement pertaining to claims 1, 3-4, 8–9, 12, 15–16 and 31 of the ’045
`
`patent, claim 7 of the ’907 patent, and claim 7 of the ’908 patent with prejudice pursuant to Fed.
`
`R. Civ. P. 41(a)(2).1
`
`3.
`
`The Parties stipulate that they will continue to assert their respective claims (see
`
`Dkt. No. 1, Counts I, VI, VII, X, XV, and XVI), counterclaims (see Dkt. No. 277, Counterclaim
`
`Counts I, II, XI–XIV, and XIX–XXI), and defenses (see Dkt. No. 277, Defenses 1, 2, 11–14, 19–
`
`25) with respect to only claims 17, 18, 19, 20, 21, 24, 27, and 30 of the ’045 patent, claims 1, 4, 5,
`
`6, 15, and 17 of the ’907 patent, and claims 1, 4, 5, 6, 15, and 17 of the ’908 patent.
`
`
`
`
`
`
`1 For the avoidance of doubt, affirmative defenses and counterclaims of unclean hands and
`inequitable conduct apply to entire patents, not specific claims.
`
`2
`
`
`
`Case 1:18-cv-12029-ADB Document 287 Filed 03/28/22 Page 3 of 5
`
`IT IS SO STIPULATED:
`
`Dated: March 28, 2022
`
`Andrea Martin (with permission)
`/s/
`Andrea L. Martin (BBO# 666117)
`BURNS & LEVINSON LLP
`125 High Street
`Boston, MA 02110-1624
`(617) 345-3000
`amartin@burnslev.com
`
`Emily R. Gabranski
`Marta Garcia Daneshvar
`Lulu Wang
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`2 Seaport Lane
`Boston, MA 02210-2001
`Emily.Gabranski@finnegan.com
`Marta.Garcia@finnegan.com
`Lulu.Wang@finnegan.com
`
`Mark J. Stewart
`Sanjay M. Jivraj
`ELI LILLY AND COMPANY
`Lilly Corporate Center
`Indianapolis, IN 46285
`stewart_mark@lilly.com
`sjivraj@lilly.com
`
`Charles E. Lipsey
`Ryan P. O’Quinn
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`1875 Explorer Street
`Suite 800
`Reston, VA 20190-6023
`Charles.Lipsey@finnegan.com
`oquinnr@finnegan.com
`
`William B. Raich
`Danielle A. Duszczyszyn
`Denise Main
`Pier D. DeRoo
`Matthew J. Luneack
`
`
`
`
`
`/s/ _Elaine Herrmann Blais__
`Douglas J. Kline (BBO# 556680)
`Elaine Herrmann Blais (BBO# 656142)
`Robert Frederickson III (BBO# 670111)
`Joshua S. Weinger (BBO# 690814)
`Alexandra Lu (BBO# 691114)
`Eric T. Romeo (BBO# 691591)
`Kathleen A. McGuinness (BBO# 693760)
`Shaobo Zhu (BBO# 697669)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`dkline@goodwinlaw.com
`eblais@goodwinlaw.com
`rfrederickson@goodwinlaw.com
`jweinger@goodwinlaw.com
`alu@goodwinlaw.com
`eromeo@goodwinlaw.com
`kmcguinness@goodwinlaw.com
`szhu@goodwinlaw.com
`
`I. Neel Chatterjee (pro hac vice)
`GOODWIN PROCTER LLP
`601 Marshall St.
`Redwood City, CA 94063
`Tel.: (650) 752-3100
`Fax: (650) 853-1038
`nchatterjee@goodwinlaw.com
`
`Natasha Daughtrey (pro hac vice)
`GOODWIN PROCTER LLP
`601 S. Figueroa St.
`Los Angeles, CA 90017
`Tel.: (213) 426-2500
`Fax: (213) 623-1673
`ndaughtrey@goodwinlaw.com
`
`Attorneys for Plaintiffs
`
`
`3
`
`
`
`Case 1:18-cv-12029-ADB Document 287 Filed 03/28/22 Page 4 of 5
`
`Yoonjin Lee
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`William.Raich@finnegan.com
`Danielle.Duszczyszyn@finnegan.com
`Denise.Main@finnegan.com
`Pier.Deroo@finnegan.com
`Matthew.Luneack@finnegan.com
`Yoonjin.Lee@finnegan.com
`
`Attorneys for Defendant
`
`
`
`
`
`
`4
`
`
`
`Case 1:18-cv-12029-ADB Document 287 Filed 03/28/22 Page 5 of 5
`
`IT IS SO ORDERED.
`
`(cid:22)(cid:18)(cid:21)(cid:27)(cid:18)(cid:21)(cid:19)(cid:21)(cid:21)
`Dated:_________________
`
`____________________________
`Hon. Allison D. Burroughs
`United States District Judge
`
`5
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
